All patients
DISEASE
From January of 2014 to August 2020, a total of 52 patients underwent laparoscopic exploration for possible laparoscopic CRS/HIPEC, including the 18 trial patients. The procedure was converted to open in 21 cases (40%), because of underestimation of the PCI (A comparison of baseline, disease-related, operative, and postoperative variables between the laparoscopic and open groups is shown in Table Comparison of baseline demographic, disease-related, operative, and postoperative variables for patients with PCI The median follow-up for the entire group was 24.0 months (38.4 months for the laparoscopic group versus 17.0 months for the open group). Table Factors associated with disease free and overall survival in 170 patients with PSM of GI primary origin with PCI The comparative analyses were repeated on an intention-to-treat basis comparing the 52 patients who underwent laparoscopic or laparoscopic-converted-to-open CRS/HIPEC to 139 who had planned open CRS/HIPEC. The findings were similar with significantly reduced PCI, EBL, time to return of bowel function, LOS, and overall 30-day morbidity in the laparoscopic group (data not shown). The only independent predictor of DFS on this analysis was receipt of prior chemotherapy (HR 6.47, 95% CI 2.18, 19.23, 